ZEPP Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Zepp Health Corp (ZEPP) is not a strong buy at the moment for a beginner, long-term investor with $50,000-$100,000 available for investment. The stock shows bearish technical indicators, no significant trading trends, and weak financial performance despite revenue growth. Additionally, there are no recent positive news or catalysts to support a strong upward movement. It is recommended to hold off on buying until clearer positive signals emerge.
The technical indicators for ZEPP are bearish. The MACD histogram is negative and expanding downward (-0.49), the RSI is at 19.959 indicating an oversold condition, and the moving averages are bearish (SMA_200 > SMA_20 > SMA_5). The stock is trading near its support level (S1: 11.772) but below the pivot point (14.648), suggesting downward pressure.
The stock is oversold based on RSI, which could indicate a potential rebound. Revenue increased significantly in the latest quarter (up 43.03% YoY).
Net income dropped significantly (-70.25% YoY), EPS decreased (-71.43% YoY), and there are no recent news or event-driven catalysts. The stock has a 50% chance of declining further in the next week (-2.36%).
In Q4 2025, revenue increased by 43.03% YoY to $85,165,000. However, net income dropped by 70.25% YoY to -$10,971,000, and EPS declined by 71.43% YoY to -0.04. Gross margin improved to 40.41%, up 9.72% YoY.
No recent analyst rating or price target changes are available for ZEPP.
